BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16939930)

  • 21. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
    Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
    Cancer Res; 2007 Sep; 67(18):8633-42. PubMed ID: 17875703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization.
    van Roest MH; Gouw AS; Peeters PM; Porte RJ; Slooff MJ; Fidler V; de Jong KP
    Ann Surg; 2008 Jul; 248(1):97-103. PubMed ID: 18580212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of immunohistochemically detected HER-2/neu (c-erbB-2) with histological stage and perineural invasion in pancreatic cancer.
    Tamiolakis D; Venizelos I; Simopoulos C; Kotini A; Jivannakis T; Papadopoulos N
    Hepatogastroenterology; 2004; 51(56):334-7. PubMed ID: 15086152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperglycemia promotes the perineural invasion in pancreatic cancer.
    Li J; Ma Q
    Med Hypotheses; 2008 Sep; 71(3):386-9. PubMed ID: 18571873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer.
    Xin B; He X; Wang J; Cai J; Wei W; Zhang T; Shen X
    Pancreatology; 2016; 16(6):1005-1014. PubMed ID: 27654574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats].
    Liang S; Yang ZL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):109-13. PubMed ID: 17344598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
    Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
    Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of MUC1 in advanced pancreatic cancer.
    Hinoda Y; Ikematsu Y; Horinochi M; Sato S; Yamamoto K; Nakano T; Fukui M; Suehiro Y; Hamanaka Y; Nishikawa Y; Kida H; Waki S; Oka M; Imai K; Yonezawa S
    J Gastroenterol; 2003; 38(12):1162-6. PubMed ID: 14714254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
    Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
    Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.
    Hong SN; Lee JK; Choe WH; Ha HY; Park K; Sung IK; Lee KT; Kim JJ; Rhee JC
    Oncol Rep; 2009 Feb; 21(2):425-30. PubMed ID: 19148518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
    Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
    Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis.
    Liu HT; Kuo HC
    Urology; 2007 Sep; 70(3):463-8. PubMed ID: 17905097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
    Yamaguchi H; Shimizu M; Ban S; Koyama I; Hatori T; Fujita I; Yamamoto M; Kawamura S; Kobayashi M; Ishida K; Morikawa T; Motoi F; Unno M; Kanno A; Satoh K; Shimosegawa T; Orikasa H; Watanabe T; Nishimura K; Ebihara Y; Koike N; Furukawa T
    Am J Surg Pathol; 2009 Aug; 33(8):1164-72. PubMed ID: 19440145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dissociated expression of protein and messenger RNA of DPC4 in human invasive ductal carcinoma of the pancreas and their implication for patient outcome.
    Toga T; Nio Y; Hashimoto K; Higami T; Maruyama R
    Anticancer Res; 2004; 24(2C):1173-8. PubMed ID: 15154643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
    Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma.
    Torer N; Kayaselcuk F; Nursal TZ; Yildirim S; Tarim A; Nòyan T; Karakayali H
    J Surg Oncol; 2007 Oct; 96(5):419-23. PubMed ID: 17874463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas.
    Kashima K; Ohike N; Mukai S; Sato M; Takahashi M; Morohoshi T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):86-90. PubMed ID: 18234645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical significance of heparanase expression in human pancreatic carcinoma tissue].
    Chen J; Lei C; DU M; Li WB; Tang HK
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1502-4. PubMed ID: 19094632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.